| Sequence 1: | NP_858058.1 | Gene: | OGT / 8473 | HGNCID: | 8127 | Length: | 1046 | Species: | Homo sapiens |
|---|---|---|---|---|---|---|---|---|---|
| Sequence 2: | NP_001385644.1 | Gene: | Ogt / 26295 | RGDID: | 62060 | Length: | 1046 | Species: | Rattus norvegicus |
| Alignment Length: | 1046 | Identity: | 1041/1046 - (99%) |
|---|---|---|---|
| Similarity: | 1046/1046 - (100%) | Gaps: | 0/1046 - (0%) |
- Green bases have known domain annotations that are detailed below.
|
Human 1 MASSVGNVADSTEPTKRMLSFQGLAELAHREYQAGDFEAAERHCMQLWRQEPDNTGVLLLLSSIH 65
Human 66 FQCRRLDRSAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEAIEHYRHALRLKPDFIDGYINLA 130
Human 131 AALVAAGDMEGAVQAYVSALQYNPDLYCVRSDLGNLLKALGRLEEAKACYLKAIETQPNFAVAWS 195
Human 196 NLGCVFNAQGEIWLAIHHFEKAVTLDPNFLDAYINLGNVLKEARIFDRAVAAYLRALSLSPNHAV 260
Human 261 VHGNLACVYYEQGLIDLAIDTYRRAIELQPHFPDAYCNLANALKEKGSVAEAEDCYNTALRLCPT 325
Human 326 HADSLNNLANIKREQGNIEEAVRLYRKALEVFPEFAAAHSNLASVLQQQGKLQEALMHYKEAIRI 390
Human 391 SPTFADAYSNMGNTLKEMQDVQGALQCYTRAIQINPAFADAHSNLASIHKDSGNIPEAIASYRTA 455
Human 456 LKLKPDFPDAYCNLAHCLQIVCDWTDYDERMKKLVSIVADQLEKNRLPSVHPHHSMLYPLSHGFR 520
Human 521 KAIAERHGNLCLDKINVLHKPPYEHPKDLKLSDGRLRVGYVSSDFGNHPTSHLMQSIPGMHNPDK 585
Human 586 FEVFCYALSPDDGTNFRVKVMAEANHFIDLSQIPCNGKAADRIHQDGIHILVNMNGYTKGARNEL 650
Human 651 FALRPAPIQAMWLGYPGTSGALFMDYIITDQETSPAEVAEQYSEKLAYMPHTFFIGDHANMFPHL 715
Human 716 KKKAVIDFKSNGHIYDNRIVLNGIDLKAFLDSLPDVKIVKMKCPDGGDNADSSNTALNMPVIPMN 780
Human 781 TIAEAVIEMINRGQIQITINGFSISNGLATTQINNKAATGEEVPRTIIVTTRSQYGLPEDAIVYC 845
Human 846 NFNQLYKIDPSTLQMWANILKRVPNSVLWLLRFPAVGEPNIQQYAQNMGLPQNRIIFSPVAPKEE 910
Human 911 HVRRGQLADVCLDTPLCNGHTTGMDVLWAGTPMVTMPGETLASRVAASQLTCLGCLELIAKNRQE 975
Human 976 YEDIAVKLGTDLEYLKKVRGKVWKQRISSPLFNTKQYTMELERLYLQMWEHYAAGNKPDHMIKPV 1040
Human 1041 EVTESA 1046 |
| Gene | Sequence | Domain | Region | External ID | Identity |
|---|---|---|---|---|---|
| OGT | NP_858058.1 | TPR 1 | 21..54 | 32/32 (100%) | |
| TPR repeat | 24..49 | CDD:276809 | 24/24 (100%) | ||
| PilF | 32..121 | CDD:442297 | 88/88 (100%) | ||
| TPR repeat | 57..83 | CDD:276809 | 25/25 (100%) | ||
| TPR | 82..289 | CDD:440225 | 206/206 (100%) | ||
| TPR 2 | 89..122 | 32/32 (100%) | |||
| TPR repeat | 89..117 | CDD:276809 | 27/27 (100%) | ||
| TPR repeat | 122..152 | CDD:276809 | 29/29 (100%) | ||
| TPR 3 | 123..156 | 32/32 (100%) | |||
| TPR 4 | 157..190 | 32/32 (100%) | |||
| TPR repeat | 157..185 | CDD:276809 | 27/27 (100%) | ||
| LapB | 190..457 | CDD:442196 | 266/266 (100%) | ||
| TPR 5 | 191..224 | 32/32 (100%) | |||
| TPR repeat | 191..219 | CDD:276809 | 27/27 (100%) | ||
| TPR 6 | 225..258 | 32/32 (100%) | |||
| TPR repeat | 226..253 | CDD:276809 | 26/26 (100%) | ||
| TPR 7 | 259..292 | 32/32 (100%) | |||
| TPR repeat | 259..287 | CDD:276809 | 27/27 (100%) | ||
| TPR 8 | 293..326 | 32/32 (100%) | |||
| TPR repeat | 293..321 | CDD:276809 | 27/27 (100%) | ||
| TPR 9 | 327..360 | 32/32 (100%) | |||
| TPR repeat | 327..355 | CDD:276809 | 27/27 (100%) | ||
| TPR repeat | 360..390 | CDD:276809 | 29/29 (100%) | ||
| TPR 10 | 361..394 | 32/32 (100%) | |||
| TPR 11 | 395..428 | 32/32 (100%) | |||
| TPR repeat | 395..423 | CDD:276809 | 27/27 (100%) | ||
| TPR 12 | 429..462 | 32/32 (100%) | |||
| TPR repeat | 429..457 | CDD:276809 | 27/27 (100%) | ||
| TPR 13, truncated | 463..473 | 9/9 (100%) | |||
| DFP motif. /evidence=ECO:0000269|PubMed:27713473 | 464..466 | 1/1 (100%) | |||
| Glyco_transf_41 | 476..1016 | CDD:404688 | 534/539 (99%) | ||
| Nuclear localization signal. /evidence=ECO:0000255 | 487..503 | 14/15 (93%) | |||
| Required for phosphatidylinositol 3,4,5-triphosphate binding. /evidence=ECO:0000250|UniProtKB:P56558 | 991..1010 | 17/18 (94%) | |||
| Ogt | NP_001385644.1 | TPR 3 | 123..156 | 32/32 (100%) | |
| TPR 4 | 157..190 | 32/32 (100%) | |||
| TPR repeat | 157..185 | CDD:276809 | 27/27 (100%) | ||
| LapB | 190..457 | CDD:442196 | 266/266 (100%) | ||
| TPR 5 | 191..224 | 32/32 (100%) | |||
| TPR repeat | 191..219 | CDD:276809 | 27/27 (100%) | ||
| TPR 6 | 225..258 | 32/32 (100%) | |||
| TPR repeat | 226..253 | CDD:276809 | 26/26 (100%) | ||
| TPR 7 | 259..292 | 32/32 (100%) | |||
| TPR repeat | 259..287 | CDD:276809 | 27/27 (100%) | ||
| TPR 8 | 293..326 | 32/32 (100%) | |||
| TPR repeat | 293..321 | CDD:276809 | 27/27 (100%) | ||
| TPR 9 | 327..360 | 32/32 (100%) | |||
| TPR repeat | 327..355 | CDD:276809 | 27/27 (100%) | ||
| TPR repeat | 360..390 | CDD:276809 | 29/29 (100%) | ||
| TPR 10 | 361..394 | 32/32 (100%) | |||
| TPR 11 | 395..428 | 32/32 (100%) | |||
| TPR repeat | 395..423 | CDD:276809 | 27/27 (100%) | ||
| TPR 12 | 429..462 | 32/32 (100%) | |||
| TPR repeat | 429..457 | CDD:276809 | 27/27 (100%) | ||
| TPR 13, truncated | 463..473 | 9/9 (100%) | |||
| DFP motif. /evidence=ECO:0000250|UniProtKB:O15294 | 464..466 | 1/1 (100%) | |||
| Glyco_transf_41 | 476..1016 | CDD:404688 | 534/539 (99%) | ||
| Nuclear localization signal. /evidence=ECO:0000255 | 488..503 | 13/14 (93%) | |||
| Required for phosphatidylinositol 3,4,5-triphosphate binding. /evidence=ECO:0000269|PubMed:18288188 | 991..1010 | 17/18 (94%) | |||
| TPR repeat | 24..49 | CDD:276809 | 24/24 (100%) | ||
| PilF | 32..121 | CDD:442297 | 88/88 (100%) | ||
| TPR repeat | 57..83 | CDD:276809 | 25/25 (100%) | ||
| TPR | 82..289 | CDD:440225 | 206/206 (100%) | ||
| TPR 2 | 89..122 | 32/32 (100%) | |||
| TPR repeat | 89..117 | CDD:276809 | 27/27 (100%) | ||
| TPR repeat | 122..152 | CDD:276809 | 29/29 (100%) |